Skip to content

The Impact of Artificial Intelligence-Assisted Diagnosis on the Detection Rate of Gastrointestinal Tract Early Cancer and Precancerous Lesions in Primary Hospitals: A Prospective, Multicenter, Randomized Controlled Study.

The Impact of Artificial Intelligence-Assisted Diagnosis on the Detection Rate of Gastrointestinal Tract Early Cancer and Precancerous Lesions in Primary Hospitals: A Prospective, Multicenter, Randomized Controlled Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075931
Enrollment
Unknown
Registered
2023-09-20
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

the regular endoscopy examination group:Participants undergo standard endoscopic examinations, and physicians independently diagnose the presence of lesions.
the real-time artificial intelligence assisted diagnosis group:In the real-time artificial intelligence assisted diagnosis group, while conducting the examination, physicians receive real-time feedbac

Sponsors

Taizhou Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 and above who seek outpatient care at primary collaborative hospitals, and are assessed by physicians to have indications for gastrointestinal endoscopy examination.

Exclusion criteria

Exclusion criteria: 1.Presence of contraindications to undergoing endoscopic examination. 2.Oral anticoagulant medication.

Design outcomes

Primary

MeasureTime frame
the detection rate of early-stage gastrointestinal cancers and precancerous lesions;the incidence rate of adverse events related to endoscopic examinations;

Countries

China

Contacts

Public ContactYiwei Fu

Taizhou Hospital Affiliated to Nanjing Medical University

fuyiwei20230419@njmu.edu.cn+86 138 1599 4588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026